341 evolution "https:" "https:" "https:" "https:" "https:" "Leiden University" positions at University of Nottingham
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
to establish a research career, allowing bespoke projects to be developed that are within the EPSRC remit. The scheme aims to provide career development beyond the end of the PhD and specifically to increase
-
university closure days including closure between Christmas and New Year. • We are committed to staff development through the provision of training, continued support, and career progression opportunities
-
of Medicine recognise the importance of continuous professional development and therefore the importance of providing opportunities, structured support and encouragement to engage in professional development
-
work We are committed to staff development through the provision of training, continued support, and career progression opportunities You will have access to a range of benefits and rewards, including
-
of salary sacrifice options enabling you to save money on childcare, shopping, and other services. Opportunities for staff development through the provision of training, continued support and options
-
days (or pro rata) plus standard bank holidays and five university closure days including closure between Christmas and New Year. • We are committed to staff development through the provision
-
in design practice. In collaboration with course directors and colleagues, the successful candidate will also contribute to curriculum development, student recruitment and the running
-
. · Our reward scheme grants bonuses of numerous values for excellent work · We are committed to staff development through the provision of training, continued support, and career progression opportunities
-
career development. The MTC is an independent Research and Technology Organisation (RTO) focused on accelerating disruptive technologies in UK manufacturing. Supported by the government, it partners with
-
Pharmacokinetics (DMPK) development of novel host-centric antiviral candidates. This work will be based within the Division of Division of Molecular Therapeutics and Formulation, located within the School